Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member

EMBO Journal

Volumn 16, Issue 1, 1997, Pages 143-153

  Liu, Shaofan ^c   Liu, Pingfan ^c   Borras, Ana ^a   Chatila, Talal ^b   Speck, Samuel H ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

BZLF1 promoter; Cyclosporin A sensitive induction; Epstein Barr virus; MEF2D

Indexed keywords

CALCINEURIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; PHORBOL ESTER; PROTEIN KINASE (CALCIUM,CALMODULIN); TACROLIMUS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; DRUG SENSITIVITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; VIRUS ACTIVATION;

BINDING SITES; CALCINEURIN; CALCIUM; CALMODULIN-BINDING PROTEINS; CYCLOSPORINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; IMMUNOSUPPRESSIVE AGENTS; MYOGENIC REGULATORY FACTORS; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASE; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VIRAL PROTEINS; VIRUS ACTIVATION;

EID: 0031016035     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.1.143     Document Type: Article

References (56)

1. Ausebel, F.M. Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. (1992) Short Protocols in Molecular Biology, 2nd edn. John Wilev & Sons, New York, NY.
2. Baer, R. et al. (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature, 310, 207-209.
3. Bauer, G., Hofler, P. and zur Hausen, H. (1982) Epstein-Barr virus induciton by a serum factor: I. induction and cooperation with additional inducers. J. Virol., 121, 184-194.
4. 2 signalling motif found in the cytoplasmic segments of the bovine leukemia virus envelope protein and Epstein-Barr virus latent membrane 2A can elicit early and late lymphocyte activation events. EMBO J., 12, 5105-5112.
5. Borras, A.M., Strominger, J.L. and Speck, S.H. (1996) Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction. J. Virol., 70, 3894-3901.
6. Breitbart, R.E., Liang, C.S., Smoot, L.B., Laheru, D.A., Mahdavi, V. and Nadal, B. (1993) A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development, 118, 1095-1106.
7. Chevalier-Greco, A., Manet, E., Chavrier, P., Mosnier, C. Daillie, J. and Sarseant, A. (1986) Both Epstein-Barr virus-encoded trans-acting factors, EB2 and EB2, are required to activate transcription from an EBV early promoter. EMBO J., 5, 3243-3249.
8. Cohen, L.K., Speck, S.H., Roberts, B.E. and Strominger, J.L. (1984) Identification and mapping of polypeptides encoded by the P3HR-1 strain of Epstein-Barr virus. Proc. Natl Acad. Sci. USA, 81, 4183-4187.
9. Countryman, J. and Miller, G. (1985) Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small subfragment of heterogenous viral DNA. Proc. Natl Acad. Sci. USA, 82, 4085-4089.
10. Countryman, J., Jenson, H., Seibel, H., Wolf, H. and Miller, G. (1987) Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr virus disrupt latency. J. Virol., 61, 3672-3679.
11. Crabtree, G.R. and Clipstone, N.A. (1994) Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem., 63, 1045-1083.
12. 2+/calmodulin-dependent protein-kinase type IV expressed in insect cells. J. Biol. Chem., 268, 26171-26178.
13. Daibata, M., Speck, S.H., Mulder, C. and Takeshi, S. (1994) Regulation of BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin treated B cells. Virology, 198, 446-454.
14. de Wet, J.R., Wodd, K.V., DeLuca, M., Helinski, D.R. and Subramani, S. (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol., 7, 725-737.
15. 2+/calmodulin-dependent protein kinase IV. Role in transcriptional regulation. J. Biol. Chem., 269, 15520-15527.
16. Faggioni, A.C., Zompetta, C. Grimaldi, S., Barile, G., Frati, L. and Lazdins, J. (1986) Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science, 232, 1554-1556.
17. Farrell, P.J., Rowe, D.T., Rooney, C.M. and Kouzarides, T. (1989) Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J., 8, 127-132.
18. Flemington, E.K. and Speck, S.H. (1990a) Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol., 64, 1217-1226.
19. Flemington, E.K. and Speck, S.H. (1990b) Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol., 64, 1227-1232.
20. Flemington, E.K., Goldfeld, A.E. and Speck, S.H. (1991) Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 gene requires protein synthesis. J. Virol., 65, 7073-7077.
21. Flemington, E.K., Borras, A.M., Lytle, J.P. and Speck, S.H. (1992) Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain. J. Virol. 66, 922-929.
22. Goldfeld, A.E., Liu, P., Liu, S., Flemington, E.K. and Speck, S.H. (1995) Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin. Virology, 209, 225-229.
23. Gorman, C.M., Moffat, L.F. and Howard, B.H. (1982) Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol., 2, 1044-1051.
24. Grogan, E., Jensen, H., Countryman, J., Heston, L., Gradoville, L. and Miller, G. (1987) Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. Proc. Natl Acad. Sci. USA, 84, 1332-1336.
25. Harwick, J.M. Lieberman, P.M. and Hayward, S.D. (1988) A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J. Virol., 62, 2274-2284.
26. 2+/calmodulin kinase type IV/Gr. J. Exp. Med., 184, 101-112.
27. Ho, S.N., Thomas, D.J., Timmerman, L.A., Li, X., Francke, U. and Crabtree, G.R. (1995) NFATc3, a lymphoid-specific NFATc family member, that is calcium-regulated and exhibits distinct DNA binding specificity. J. Biol. Chem., 270, 19898-19907.
28. Hummel, M. and Kieff, E. (1982) Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection. Proc. Natl Acad. Sci. USA, 79, 5698-5702.
29. Jain, J., McCaffrey, P.G., Valge-Archer, V.E. and Roa, A. (1992) Nuclear factor of activate T cells contains Fos and Jun. Nature. 356, 801-804.
30. Jain, J., McCaffrey, P.G., Miner, Z., Kerppola, T.K., Lambert, J.N., Verdine, G.L., Curran, T. and Rao, A. (1993) The T cell transcription factor NFATp is a substrate for calcineurin and interacts with the DNA-binding domain of fos and jun. Nature, 365, 352-355.
31. Leifer, D. et al. (1993) MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc. Natl Acad. Sci. USA, 90, 1546-1550.
32. Lonsnecker, R. and Miller, C.L. (1996) Regulation of Epstein-Barr virus latency by latent membrane protein 2. Trends Microbiol., 4, 38-42.
33. Maniatis, T., Fritsch, E.F. and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
34. Martin, J.F. Miano, J.M., Hustad, C.M., Copeland, N.G., Jenkins, N.A. and Olson, E.N. (1994) A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol., 14, 1647-1656.
35. Mathets, R.P., Guthrie, C.R., Wailes, L.M. Zhao, X., Means, A.R. and McKnigh, G.S. (1994) Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol. Cell. Biol., 14, 6107-6116.
36. McCaffrey, P.G., Goldfeld, A.E. and Rao, A.E. (1994) The role of NFATp in cyclosporin A-sensitive tumor necrosis factor alpha gene induction. J. Biol. Chem., 269, 30445-30450.
37. McDermott, J.C., Cardoso, M.C., Yu, Y.T. Andres, V., Liefer, D., Krainc, D., Lipton, S.A. and Nadal, G.B. (1993) hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol. Cell. Biol., 13, 2564-2577.
38. Miller, C.L., Burkhardt, A.L., Lee, J.H., Stealey, B., Longnecker, R., Bolen, J.B. and Kieff, E. (1995) Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity, 2, 155-166.
39. Miller, G., Rabson, M. and Heston, L. (1984) Epstein-Barr virus with heterogenous DNA disrupts latency. J. Virol., 50, 174-182
40. 2+/calmodulin-dependent kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by the Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1. J. Virol., 68, 1697-1705.
41. Northrop, J.P., Ullman, K.S. and Crabtree, G.R. (1993) Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J. Biol. Chem., 268, 2917-2923.
42. Northrop, J.P., Ho, S.N., Chen, L., Thomas, D.J., Timmerman, L.A., Nolan, G.P., Admon, A. and Crabtree, G.R. (1994) NF-AT components define a family of transcription factors targeted in T cell activation. Nature, 369, 497-502.
43. Pollock, R. and Treisman, R. (1991) Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev., 5, 2327-2341.
44. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science, 252, 1427-1430.
45. Shimizu, N. and Takada, K. (1993) Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence. J. Virol., 67, 3240-3245.
46. Singh, H., Sen, R., Baltimore, D. and Sharp, P.A. (1986) A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature, 319, 154-158.
47. Songyang, Z. et al. (1993) SH2 domains recognize specific phospho-peptide sequences. Cell, 72, 767-778.
48. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev., 8, 2527-2539.
49. Takada, K. and Ono, Y. (1989) Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol., 63, 445-449.
50. Takada, K., Shimizu, N., Sakuma, S. and Ono, Y. (1986) Transactivation of the latent Epstein-Barr virus genome after transfection of EBV DNA fragment. J. Virol., 57, 1016-1022.
51. Tovey, M., Lenoir, G. and Lours-Begon, J. (1978) Activation of latent Epstein-Barr virus by antibody to human IgM. Nature, 276, 270-272.
52. Tsai, E.Y., Jain, J., Pesavento, P.A., Rao, A. and Goldfeld, A. (1996) Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-1/Jun and NFATp. Mol. Cell. Biol., 16, 459-467.
53. Weiss, A. and Littman, D.R. (1994) Signal transduction by lymphocyte antigen receptors. Cell, 76, 263-274.
54. Woronicz, J.D., Lina, A., Calnan, B.J., Szychowski, S., Cheng, L. and Winoto, A. (1995) Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol. Cell. Biol., 15, 6364-6367.
55. Yu, Y.-T. Breitbart, R.E., Smoot, L.B., Lee, Y., Mahdavi, V. and Nadal-Ginard, B. (1992) Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev., 6, 1783-1798.
56. zur Hausen, H., O'Neil, F. and Freese, U. (1978) Persisting oncogenic herpes virus induced by the tumor promoter TPA. Nature, 272, 373-375.